Viridian Therapeutics, Inc.
VRDN· Nasdaq
VRDNViridian Therapeutics, Inc.
Filed May 16, 2016 · 10-Q · 46 days after period end · 0001171843-16-010081
| Metric | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|
| Revenue | $2.05M | $1.32M | $1.48M |
| Net Income | -$2.76M | -$2.63M | -$706.00K |
| EPS Diluted | -$5.58 | -$0.45 | -$3.53 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Viridian Therapeutics, Inc. · CIK 1590750 · Engraved from SEC EDGAR
ended Mar 31, 2016 · filed May 16, 2016 · 46 d after period end
